Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2,5,8,11-Tetraoxatridecan-13-ol, 1,1,1-triphenylis a complex organic compound characterized by its unique molecular structure, which includes a trityl group, a PEG linker, and a terminal hydroxyl group. The trityl group can be removed under acidic conditions, while the hydroxyl group allows for further derivatization of the compound. The presence of hydrophilic PEG linkers enhances the solubility of the compound in aqueous media, making it suitable for various applications.

125274-16-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 125274-16-0 Structure
  • Basic information

    1. Product Name: 2,5,8,11-Tetraoxatridecan-13-ol, 1,1,1-triphenyl-
    2. Synonyms: 2,5,8,11-Tetraoxatridecan-13-ol, 1,1,1-triphenyl-;Tr-PEG5;1,1,1-triphenyl-2,5,8,11-tetraoxatridecan-13-ol;1,1,1-triphenyl-2,5,8,11-tetraoxatridecan-13-ol(WXPC0040)
    3. CAS NO:125274-16-0
    4. Molecular Formula: C27H32O5
    5. Molecular Weight: 436.53998
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 125274-16-0.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 2,5,8,11-Tetraoxatridecan-13-ol, 1,1,1-triphenyl-(CAS DataBase Reference)
    10. NIST Chemistry Reference: 2,5,8,11-Tetraoxatridecan-13-ol, 1,1,1-triphenyl-(125274-16-0)
    11. EPA Substance Registry System: 2,5,8,11-Tetraoxatridecan-13-ol, 1,1,1-triphenyl-(125274-16-0)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 125274-16-0(Hazardous Substances Data)

125274-16-0 Usage

Uses

Used in Pharmaceutical Industry:
2,5,8,11-Tetraoxatridecan-13-ol, 1,1,1-triphenylis used as a pharmaceutical candidate for enhancing the solubility and bioavailability of drugs. The hydrophilic PEG linkers improve the compound's solubility in aqueous media, which can be beneficial for drug delivery and absorption.
Used in Chemical Synthesis:
2,5,8,11-Tetraoxatridecan-13-ol, 1,1,1-triphenylis used as a synthetic intermediate for the development of various chemical compounds. The terminal hydroxyl group allows for further derivatization, enabling the creation of new molecules with specific properties and applications.
Used in Material Science:
2,5,8,11-Tetraoxatridecan-13-ol, 1,1,1-triphenylcan be utilized in the development of novel materials with enhanced properties. The compound's unique structure and the ability to undergo further chemical reactions make it a valuable component in the design and synthesis of advanced materials for various industries.
Used in Research and Development:
2,5,8,11-Tetraoxatridecan-13-ol, 1,1,1-triphenylserves as a valuable research tool for studying the properties and behavior of complex organic compounds. Its unique structure and functional groups make it an interesting subject for scientific investigation, potentially leading to new discoveries and applications in various fields.

Check Digit Verification of cas no

The CAS Registry Mumber 125274-16-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,5,2,7 and 4 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 125274-16:
(8*1)+(7*2)+(6*5)+(5*2)+(4*7)+(3*4)+(2*1)+(1*6)=110
110 % 10 = 0
So 125274-16-0 is a valid CAS Registry Number.

125274-16-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-[2-[2-(2-trityloxyethoxy)ethoxy]ethoxy]ethanol

1.2 Other means of identification

Product number -
Other names 2-(2-(2-(2-(trityloxy)ethoxy)ethoxy)ethoxy)ethanol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:125274-16-0 SDS

125274-16-0Relevant articles and documents

Synthesis of a series of oligo(ethylene glycol)-terminated alkanethiol amides designed to address structure and stability of biosensing interfaces

Svedhem,Hollander,Shi,Konradsson,Liedberg,Svensson

, p. 4494 - 4503 (2001)

A strategy for the synthesis of a series of closely related oligo(ethylene glycol)-terminated alkanethiol amides (principally HS(CH2)mCONH(CH2CH2O) nH; m = 2, 5, 11, 15, n = 1, 2, 4, 6, 8, 10, 12) and analogous esters has been developed. These compounds were made to study the structure and stability of self-assembled monolayers (SAMs) on gold in the prospect of designing new biosensing interfaces. For this purpose, monodisperse heterofunctional oligo(ethylene glycols) with up to 12 units were prepared. Selective monoacylation of the symmetrical tetra- and hexa(ethylene glycol) diols as their mesylates with the use of silver(I) oxide was performed. The synthetic approach was based on carbodiimide couplings of various oligo(ethylene glycol) derivatives to ω-(acetylthio) carboxylic acids via a terminal amino or hydroxyl function. SAM structures on gold were studied with respect to thickness, wettability (water contact angles ~30°), and conformation. A good fit was obtained for the relation between monolayer thickness (d) and the number of units in the oligo(ethylene glycol) chain (n): d = 2.8n + 21.8 (A). Interestingly, the corresponding infrared spectroscopy analysis showed a dramatic change in conformation of the oligomeric chains from all-trans (n = 4) to helical (n ≥ 6) conformation. A crystalline helical structure was observed in the SAMs for n > 6.

METHOD FOR SYNTHESIS OF PROTEIN AMPHIPHILES

-

Paragraph 0232-0238, (2020/07/14)

The present invention discloses a novel cost effective method for synthesis of protein/peptide amphiphiles irrespective of functional and structural classification of proteins useful in designing a vaccine candidate from antigenic protein. The protein modification of the present invention is universal and hence any protein/peptide can be converted into amphiphilic proteins/peptides.

Optimization of IEDDA bioorthogonal system: Efficient process to improve trans-cyclooctene/tetrazine interaction

Béquignat, Jean-Baptiste,Boucheix, Claude,Canitrot, Damien,Chezal, Jean-Michel,Degoul, Fran?oise,Miot-Noirault, Elisabeth,Moreau, Emmanuel,Navarro-Teulon, Isabelle,Quintana, Mercedes,Rondon, Aurélie,Taiariol, Ludivine,Ty, Nancy

supporting information, (2020/07/21)

The antibody pretargeting approach for radioimmunotherapy (RIT) using inverse electron demand Diels-Alder cycloaddition (IEDDA) constitutes an emerging theranostic approach for solid cancers. However, IEDDA pretargeting has not reached clinical trial. The major limitation of the IEDDA strategy depends largely on trans-cyclooctene (TCO) stability. Indeed, TCO may isomerize into the more stable but unreactive cis-cyclooctene (CCO), leading to a drastic decrease of IEDDA efficiency. We have thus developed both efficient and reproducible synthetic pathways and analytical follow up for (PEGylated) TCO derivatives, providing high TCO isomeric purity for antibody modification. We have set up an original process to limit the isomerization of TCO to CCO before the mAbs’ functionalization to allow high TCO/tetrazine cycloaddition.

DENDRITIC POLYETHYLENE GLYCOL DERIVATIVE, AND PREPARATION METHOD AND APPLICATION THEREOF

-

Paragraph 0167-0168, (2020/05/14)

The disclosure discloses a dendritic polyethylene glycol derivative and a preparation method and an application thereof. The dendritic polyethylene glycol derivative has a structure of formula (I), has multiple end functional groups, has a stronger water solubility in comparison with linear-chain polyethylene glycol, and can solve a problem of insufficient water solubility due to the increase of load when modifying an insoluble drug by the polyethylene glycol. The preparation method of the dendritic polyethylene glycol derivative provided by the disclosure has mild reaction conditions, is green and environmentally friendly, is low in cost, and is easy to implement industrialization.

Ligand-Phospholipid Conjugation: A Versatile Strategy for Developing Long-Acting Ligands That Bind to Membrane Proteins by Restricting the Subcellular Localization of the Ligand

Kawamura, Shuhei,Ito, Yoshihiko,Hirokawa, Takatsugu,Hikiyama, Eriko,Yamada, Shizuo,Shuto, Satoshi

, p. 4020 - 4029 (2018/05/07)

We hypothesized that if drug localization can be restricted to a particular subcellular domain where their target proteins reside, the drugs could bind to their target proteins without being metabolized and/or excreted, which would significantly extend the half-life of the corresponding drug-target complex. Thus, we designed ligand-phospholipid conjugates in which the ligand is conjugated with a phospholipid through a polyethylene glycol linker to restrict the subcellular localization of the ligand in the vicinity of the lipid bilayer. Here, we present the design, synthesis, pharmacological activity, and binding mode analysis of ligand-phospholipid conjugates with muscarinic acetylcholine receptors as the target proteins. These results demonstrate that ligand-phospholipid conjugation can be a versatile strategy for developing long-acting ligands that bind to membrane proteins in drug discovery.

Hydrophilic and Cell-Penetrable Pyrrolidinyl Peptide Nucleic Acid via Post-synthetic Modification with Hydrophilic Side Chains

Pansuwan, Haruthai,Ditmangklo, Boonsong,Vilaivan, Chotima,Jiangchareon, Banphot,Pan-In, Porntip,Wanichwecharungruang, Supason,Palaga, Tanapat,Nuanyai, Thanesuan,Suparpprom, Chaturong,Vilaivan, Tirayut

, p. 2284 - 2292 (2017/09/26)

Peptide nucleic acid (PNA) is a nucleic acid mimic in which the deoxyribose-phosphate was replaced by a peptide-like backbone. The absence of negative charge in the PNA backbone leads to several unique behaviors including a stronger binding and salt independency of the PNA-DNA duplex stability. However, PNA possesses poor aqueous solubility and cannot directly penetrate cell membranes. These are major obstacles that limit in vivo applications of PNA. In previous strategies, the PNA can be conjugated to macromolecular carriers or modified with positively charged side chains such as guanidinium groups to improve the aqueous solubility and cell permeability. In general, a preformed modified PNA monomer was required. In this study, a new approach for post-synthetic modification of PNA backbone with one or more hydrophilic groups was proposed. The PNA used in this study was the conformationally constrained pyrrolidinyl PNA with prolyl-2-aminocyclopentanecarboxylic acid dipeptide backbone (acpcPNA) that shows several advantages over the conventional PNA. The aldehyde modifiers carrying different linkers (alkylene and oligo(ethylene glycol)) and end groups (-OH, -NH2, and guanidinium) were synthesized and attached to the backbone of modified acpcPNA by reductive alkylation. The hybrids between the modified acpcPNAs and DNA exhibited comparable or superior thermal stability with base-pairing specificity similar to those of unmodified acpcPNA. Moreover, the modified apcPNAs also showed the improvement of aqueous solubility (10-20 folds compared to unmodified PNA) and readily penetrate cell membranes without requiring any special delivery agents. This study not only demonstrates the practicality of the proposed post-synthetic modification approach for PNA modification, which could be readily applied to other systems, but also opens up opportunities for using pyrrolidinyl PNA in various applications such as intracellular RNA sensing, specific gene detection, and antisense and antigene therapy.

Precursor for preparing micelle

-

Paragraph 0157; 0158, (2016/11/21)

The present invention refers to linker, polar material and two aliphatic hydrocarbon chain comprised of precursor for micellar formation, said precursor manufacturing method, including micelles and including said precursor of said micelle relates to drug delivery. In the present invention number the use of precursor for forming micelle under public affairs, two game machine included in same, non-polar tail due to, than micelles of the existing method a relatively high stability of the insertion part and the holder under trillion number micelle, micelles including drug delivery or the like and can be widely used for the development of.. (by machine translation)

Highly efficient synthesis of monodisperse poly(ethylene glycols) and derivatives through macrocyclization of oligo(ethylene glycols)

Zhang, Hua,Li, Xuefei,Shi, Qiuyan,Li, Yu,Xia, Guiquan,Chen, Long,Yang, Zhigang,Jiang, Zhong-Xing

supporting information, p. 3763 - 3767 (2015/03/18)

A macrocyclic sulfate (MCS)-based approach to monodisperse poly(ethylene glycols) (M-PEGs) and their monofunctionalized derivatives has been developed. Macrocyclization of oligo(ethylene glycols) (OEGs) provides MCS (up to a 62-membered macrocycle) as versatile precursors for a range of monofunctionalized M-PEGs. Through iterative nucleophilic ring-opening reactions of MCS without performing group protection and activation, a series of M-PEGs, including the unprecedented 64-mer (2850Da), can be readily prepared. Synthetic simplicity coupled with versatility of this new strategy may pave the way for broader applications of M-PEGs. Macrocycles make synthesis easier: Convenient macrocyclization of the OEGs provides versatile macrocyclic sulfates. These compounds are cornerstones for both monofunctionalization of OEGs and highly efficient synthesis of monodisperse PEGs and derivatives, including an unprecedented 64-mer.

Fluorous synthesis of mono-dispersed poly(ethylene glycols)

Li, Yu,Guo, Qi,Li, Xuefei,Zhang, Hua,Yu, Fanghua,Yu, Weijiang,Xia, Guiquan,Fu, Mingyang,Yang, Zhigang,Jiang, Zhong-Xing

supporting information, p. 2110 - 2113 (2014/04/03)

Mono-dispersed poly(ethylene glycols) (PEGs) are of great value in the development of biopharmaceuticals. However, tedious synthesis limits the availability of mono-dispersed PEGs. To address this issue, a fluorous synthesis of mono-dispersed PEGs, discretely PEGylated surfactants and 19F magnetic resonance imaging (MRI) agents has been developed. During the synthesis, both fluorous and normal phase silica gel-based solid-phase extractions were successfully employed to simplify the purifications. This synthesis provided an easy access to valuable mono-dispersed PEGs and related molecules for biomedical application on multi-gram scales.

Synthesis and the structure to property relationship of monoperfluoroalkyl polyethylene glycol

Jaoued-Grayaa, Najeh,Boughariou-Charrada, Boutheina,Hedhli, Ahmed

, p. 767 - 772 (2014/07/08)

Monoprotected polyethylene glycols (PEG) react with epichlorohydrin to furnish PEGylated epoxides. The latter were converted into the corresponding α-(2-F-alkylethyl)thiomethyl polyethylene glycols by treatment with 2-F-alkylethanethiol. Surface activity

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 125274-16-0